FNYS
IPCI

First New York Securities’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

First New York Securities’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,302
Closed -$26K – 427
2013
Q3 		$26K Sell
1,302
-15,072
-92% -$296K 0.01% 306
2013
Q2 		$278K Buy
+16,374
New +$302K 0.1% 145

Other funds holding IPCI

TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
AIG
American International Group New York $2.93M AUM 12.08% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

First New York Securities's IPCI Position: Q4 2013 in Review

First New York Securities sold out of Intellipharmaceuticals International Inc. (IPCI) in Q4 2013, closing a stake of 1,302 shares — an estimated $26K sold.

First New York Securities first reported a position in IPCI in Q2 2013 and held it in 2 quarters. The position peaked at $278K in Q2 2013. 13 funds tracked by Wall St. Rank hold IPCI as of Q4 2013.

  • First New York Securities reported no remaining Intellipharmaceuticals International Inc. position as of Q4 2013 after selling out during the quarter.
  • First New York Securities sold 1,302 Intellipharmaceuticals International Inc. shares in Q4 2013, an estimated $26K.
  • First New York Securities first reported a position in Intellipharmaceuticals International Inc. in Q2 2013 and held it in 2 quarters.
  • First New York Securities's Intellipharmaceuticals International Inc. position peaked at $278K in Q2 2013.
  • 13 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q4 2013.

Based on First New York Securities's 13F filing for Q4 2013, filed 12 Feb 2014.